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1. General Experimental Details: 
 
Bu2O, Et2O, methyl tert-butyl ether (MTBE), triethylamine, dichloromethane (DCM), acetonitrile 
(MeCN), and tetrahydrofuran (THF) were dried on alumina according to published procedures.1 
Cyclopentylmethyl ether (CPME) was dried over CaH2, distilled under N2, and stored in a Straus 
flask. The following reagents were purchased from commercial suppliers and used as received: 
Palladium(II) iodide (Strem), palladium(II) chloride (Strem), bis(acetonitrile)dichloropalladium(II) 
(Strem), 1-bromo-3,5-di-tert-butylbenzene (Combi Blocks), 2-chloropropane (Alfa) 2-
bromopropane (Aldrich), 2-iodopropane (Oakwood), bromocyclopentane (Acros), 1-bromobutane 
(Acros), 3-bromopentane (Alfa Aesar), exo-2-bromonorbornane (Aldrich), (1-bromoethyl)benzene 
(Aldrich), (2-bromopropyl)benzene (Aldrich), dimethylphenylsilane (Gelest), iodomethane (Acros), 
magnesium turnings (Oakwood). All chlorosilanes were generously donated by Gelest Inc. and 
used as received. The following Grignard reagents were purchased from commercial suppliers 
and titrated with iodine before use: Phenylmagnesium bromide [3 M] in Et2O (Aldrich), ortho-
tolylmagnesium bromide [2 M] in Et2O (Aldrich), 2-mesitylmagnesium bromide [1 M] in Et2O 
(Aldrich), isopropylmagnesium bromide [1 M] in THF (Aldrich), isopropylmagnesium chloride [2 M] 
in THF (Acros), isopropylmagnesium chloride lithium chloride complex [1.3 M] in THF (Acros), 
cyclopentylmagnesium bromide [2 M] in Et2O (Acros), (trimethylsilyl)methylmagnesium chloride [1 
M] in Et2O (Aldrich), and 2-methyl-2-phenylpropylmagnesium chloride [0.5 M] in Et2O (Acros). (3-
bromobutyl)benzene,2 1-(3-bromobutyl)-4-chlorobenzene,3 and 1-(3-bromobutyl)-4-
methoxybenzene,4 were prepared according to the published procedures. Vials used in the 
glovebox were dried in a gravity oven at 140 °C for a minimum of 12 h, transferred into the 
glovebox hot, and then stored at rt in the glovebox prior to use. All hot glassware was oven dried 
for a minimum of four hours or flame-dried under vacuum prior to use. “Double manifold” refers to 
a standard Schlenk-line gas manifold equipped with nitrogen and vacuum (ca. 0.100 mm Hg). All 
optimization reactions (0.25 mmol scale) were charged in a nitrogen-filled glovebox and alkyl zinc 
halide was added on the bench via syringe then stirred on a magnetic stir plate. All yields and 
branched:linear (B:L) ratios in optimization reactions were determined by GC of the unpurified 
products with 1,3,5-trimethoxybenzene and n-nonane as internal standards. All other reactions 
were set up using standard Schlenk technique and heated with stirring in temperature controlled 
oil baths. Note: Any product yields listed in the main text that do not match those listed in the 
supporting information are the average of multiple isolated yields. The procedures listed below 
reflect yields from specific experimental runs. 
 
2. Instrumentation and Chromatography: 
 
400 MHz 1H, 101 MHz 13C and 376 MHz 19F spectra were obtained on a 400 MHz FT-NMR 
spectrometer equipped with a Bruker CryoPlatform. 600 MHz 1H, 151 MHz 13C, 119 MHz 29Si, 
and 243 31P spectra were obtained on a 600 MHz FT-NMR spectrometer equipped with a Bruker 
SMART probe. All samples were analyzed in the indicated deutero-solvent and were recorded at 
ambient temperatures. All chemical shifts are reported in ppm. 1H NMR spectra were calibrated 
using the residual protio-signal in deutero-solvents as a standard. 13C NMR spectra were 
calibrated using the deutero-solvent as a standard. Product 29Si spectra were calibrated using a 
hexamethyldisiloxane capillary standard at 7.32ppm. IR spectra were recorded on a Nicolet 
Magma-IR 560 FT-IR spectrometer as thin films on KBr plates. High resolution MS data was 
obtained on a Waters GCT Premier spectrometer using chemical ionization (CI), electron 
ionization (EI), or liquid injection field desorption ionization (LIFDI). Unless otherwise noted, 
column chromatography was performed either by hand or by use of Isolera 4 Biotage unit with 40-
63 µm silica gel, and the eluent reported in parentheses. Analytical thin-layer chromatography 
(TLC) was performed on silica gel (60 F254 Merck) pre-coated glass plates and visualized by UV 
or by staining with iodine, KMnO4, or ceric ammonium molybdate. 
 
  




3. Synthesis of Ligand and Catalysts: 
 
Ligand and Catalyst Synthesis:5 
 
DrewPhos: An oven-dried 500 mL round bottom flask equipped with a 
magnetic stir bar and rubber septum was attached to a double manifold 
and cooled under vacuum. The flask was backfilled with N2, the rubber 
septum was removed, 1-bromo-3,5-di-tert-butylbenzene (32.4 g, 120 
mmol, 3.01 equiv) was added, and the septum replaced. The flask was 
then purged with N2 for 15 minutes. THF (240 mL, [0.5 M]) was added and 
the flask was cool to –78 °C in a dry ice/acetone bath. While stirring, nBuLi 
(48.2 mL, 120 mmol, 3 equiv, [2.49 M] in hexanes) was added dropwise 
via syringe pump over 30 minutes. (Note: A large amount of solids can 
form and stall reaction stirring. Swirl flask by hand to break up clumps). 
PCl3 (3.5 mL, 40 mmol, 1 equiv) was added dropwise via syringe pump 
over 15 minutes. (Note: Initial addition will begin to consume the aryl lithium and stirring will 
become easier, manual swirling may be necessary at the start of addition). After the addition was 
complete, the flask was warmed to 0 °C in an ice/water bath and stirred for 4 h. Flask was 
allowed to warm to rt, the septum was removed and the reaction was quenched by adding brine 
(100 mL). The reaction was poured into a separatory funnel and the product was extracted 2X 
with Et2O (100 mL). The organic layer was dried over MgSO4, filtered through a glass frit, and the 
solvent removed in vacuo. The product was purified by recrystallization from hot EtOH (200 mL), 
cooled under ambient conditions, then placed in a –20 °C freezer overnight. Collection of the 
solid via filtration and washing with EtOH resulted in white crystals (10.6 g, 44% yield): 1H NMR 
(600 MHz, CDCl3) δ 7.38 (t, J = 1.8 Hz, 3H), 7.12 (dd, J = 8.5, 1.8 Hz, 6H), 1.22 (s, 54H); 13C 
NMR (151 MHz, CDCl3) δ 150.6 (d, J = 6.7 Hz), 137.3 (d, J = 9.4 Hz), 128.1 (d, J = 19.3 Hz), 
122.4 , 35.0 , 31.5; 31P NMR (243 MHz, CDCl3) δ -3.59; FTIR (cm-1): 2963, 1589, 1577, 1362, 
1249, 1130, 875, 710; mp = 145–147 °C. HRMS (LIFDI) m/z, calcd for [C42H63P]+: 598.4667; 
found: 598.4688. 
 
(DrewPhos)2PdI2: A 50 mL round bottom flask 
equipped with a magnetic stirbar was charged with 
palladium(II) iodide (1.08 g, 3 mmol, 1.0 equiv) and 
DrewPhos (3.59 g, 6 mmol, 2.0 equiv). The flask 
was sealed with a rubber septum and purged 10 
min with N2. Toluene (24 mL) was added via syringe 
and the reaction was stirred for 24 hours at 85 °C. 
The reaction was cooled to rt, transferred to a 250 
mL round bottom flask and the solvent evaporated 
in vacuo. The resulting solid was recrystallized from 
hot 3:1 ethanol:toluene (100 mL), cooled under 
ambient conditions, then placed in a –20 °C freezer overnight. Collection of the solid via filtration 
resulted in a stable, red solid (3.52 g, 75% yield). A second crop of product was obtained by 
subsequent recrystallization with same solvent system resulted in red crystals (900 mg, 19%). 
Total 4.42 g, 95%: 1H NMR (600 MHz, CDCl3) δ 7.60 – 7.54 (m, 12H), 7.29 (s, 6H), 1.21 (s, 
108H); 13C NMR (151 MHz, CDCl3) δ 149.2 (t, J = 5.1 Hz), 134.5 (t, J = 24.9 Hz), 129.9 (t, J = 6.2 
Hz), 123.2, 35.1, 31.6; 31P NMR (243 MHz, CDCl3) δ 18.90 ; FTIR (cm-1): 2953, 1589, 1384, 



























4. Synthesis of Alkylmagnesium Halides: 
 
General Procedure A: 
 
An oven dried round bottom flask equipped with a magnetic stirbar and rubber septum was 
attached to a double manifold and cooled under vacuum. The flask was backfilled with N2, the 
septum removed, magnesium turnings (1.5 equiv) and a single chip of I2 (~20–30 mg) were 
added. The septum was replaced; the flask was attached to a double manifold and purged with 
N2 for 10 min. The flask was held under positive N2 then Et2O [3 M] was added. The solution was 
stirred until clarity was reached (disappearance of brown I2 color). An initial amount of alkyl halide 
(~200–400 µL) was added to start the reaction as evidenced by a minor exotherm. If reaction 
does not initiate, gentle warming (for example with a heating mantle) may be necessary. Once 
initiated, the alkyl halide was added dropwise so as to keep the mixture warm, but below full 
reflux. If desired, a reflux condenser may be used as well. After full addition of the alkyl halide, the 
flask was allowed to stir at rt for an additional 1-4 h. The excess magnesium was allowed to settle 
and the mixture was filtered via cannula to a Schlenk tube. If insoluble particles persist, filtration 
through a 0.2 µm PTFE syringe filter was employed. Solutions were then titrated according to the 
literature procedure by Knochel.6 
 
Note: Titration concentrations used in the isolation runs in Section 5 may differ from those 
reported here. The procedures listed below reflect titrations from specific experimental runs. 
 
(S1) According to general procedure A, magnesium turnings (1.1 mg, 45 mmol, 1.5 
equiv), diethyl ether (10 mL), I2 chip , and isopropyl iodide (3.0 mL, 5.1 g, 30 mmol, 
1 equiv) were combined under nitrogen and stirred for 2 h at rt. Filtration and 
titration resulted in a [1.84 M] solution of isopropylmagnesium iodide. 
 
(S2) According to general procedure A, magnesium turnings (1.1 mg, 45 mmol, 
1.5 equiv), diethyl ether (10 mL), I2 chip , and isopropyl bromide (2.8 mL, 3.69 g, 
30 mmol, 1 equiv) were combined under nitrogen and stirred for 2 h at rt. Filtration 
and titration resulted in a [2.23 M] solution of isopropylmagnesium bromide. 
 
(S3) According to general procedure A, magnesium turnings (1.1 mg, 45 mmol, 
1.5 equiv), diethyl ether (10 mL), no iodine, and isopropyl chloride (2.7 mL, 2.36 g, 
30 mmol) were combined under nitrogen and stirred for 4 h at rt. Filtration and 
titration resulted in a [2.65 M] solution of isopropylmagnesium chloride. 
 
(S4) According to general procedure A, magnesium turnings (730 mg, 30 
mmol), diethyl ether (7 mL), no iodine, and a solution of n-butyl bromide 
(2.7 mL, 3.4 g, 25 mmol) in diethyl ether (5 mL) were combined under 
nitrogen and stirred for 4 h at rt.. Filtration and titration resulted in a [1.93 M] 
solution of n-butylmagnesium bromide. 
 
(S5) According to general procedure A, magnesium turnings (300 mg, 12 
mmol), diethyl ether (3 mL), I2 chip, and solution of 3-bromopentane (1.2 mL, 
1.5 g, 10 mmol) in diethyl ether (2 mL) were combined under nitrogen and 
stirred for 4 h at rt. Filtration and titration resulted in a [0.67 M] solution of 3-
pentylmagnesium bromide. 
 
(S6) According to general procedure A, magnesium turnings (730 mg, 30 
mmol, 1.5 equiv), diethyl ether (6.7 mL), I2 chip, and (1S,4R)-2-
bromobicyclo[2.2.1]heptane (2.6 mL, 3.5 g, 20 mmol, 1 equiv) were combined 
under nitrogen and stirred 3 h at rt. Filtration and titration resulted in a [1.21 M] 
solution of bicyclo[2.2.1]heptan-2-ylmagnesium bromide in an exo:endo ratio of 41:59 by NMR 
matching literature reports.7 




(S7) According to general procedure A, magnesium turnings (730 mg, 30 
mmol), diethyl ether (7 mL), I2 chip, and solution of neopentyl bromide (3 mL, 
3.6 g, 24 mmol) in diethyl ether (5 mL). Filtration and titration resulted in a [0.95 
M] solution of neopentylmagnesium bromide. 
 
(S8) According to general procedure A, magnesium turnings (1.1 g, 45 
mmol, 1.5 equiv), I2 chip, Et2O (10 mL), and (3-bromobutyl)benzene (6.4 g, 
30 mmol, 1 equiv) were combined under nitrogen and stirred for 1 h at rt. 
Filtration and iodometric titration resulted in a [1.34 M] solution of (4-
phenylbutan-2-yl)magnesium bromide. 
 
(S9) According to general procedure A, magnesium turnings (292 mg, 
12 mmol, 1.2 equiv), I2 chip, Et2O (3.3 mL), and 1-(3-bromobutyl)-4-
chlorobenzene (2.48 g, 10 mmol, 1 equiv) were combined under 
nitrogen and stirred for 2 h at rt. Filtration and iodometric titration 
resulted in a [0.85 M] solution of (4-(4-chlorophenyl)butan-2-
yl)magnesium bromide. 
 
(S10) According to general procedure A, magnesium turnings (292 
mg, 12 mmol, 1.2 equiv), I2 chip, Et2O (3.3 mL), and 1-(3-
bromobutyl)-4-methoxybenzene (2.43 g, 10 mmol, 1 equiv) were 
combined under nitrogen and stirred for 2 h at rt. Filtration and 
iodometric titration resulted in a [0.85 M] solution of (4-(4-
methoxyphenyl)butan-2-yl)magnesium bromide. 
 
(S11) According to a modified version of general procedure A, magnesium 
turnings (1.1 g, 45 mmol, 1.5 equiv), diethyl ether (10 mL), and I2 chip were 
added. Once clarity of the solution was reached, the flask was cooled to 0 °C 
in an ice/water bath. Stirring at 0 °C, (1-bromoethyl)benzene (5.6 g, 4.1 mL, 30 
mmol, 1 equiv) was added dropwise via syringe pump over ~1 h. After addition, 










5. General Procedure for the Silyl-Kumada Reaction: 
 
Note: Reactions are run at [0.5 M] overall concentration based on the sum of all liquid reagents. 
 
General Procedure B (rt Coupling): 
 
An oven dried 10 mL Schlenk flask equipped with a magnetic stirbar and rubber septum was 
attached to a double manifold and cooled under vacuum. The flask was backfilled with N2, the 
rubber septum was removed, and (DrewPhos)2PdI2 (0.01 equiv) was added. The septum was 
replaced and the flask purged with N2 for 10 minutes. Et2O, silyl chloride (1.2 equiv), and 
alkylmagnesium halide (1 equiv) were added sequentially via syringe. The solution was then 
stirred at rt for 24 h. A vent needle was added and the reaction was quenched with EtOAc (3 mL) 
then H2O (3 mL) via syringe. The mixture was washed 2 times with brine (20 mL) and extracted 
using EtOAc or Et2O. The combined organic layer was dried over MgSO4, filtered, and the solvent 
removed in vacuo. The crude material was purified via silica gel flash chromatography in the 
indicated solvent. 
 
General Procedure C (50 °C Coupling): 
 
An oven dried 10 mL Schlenk flask equipped with a magnetic stirbar and rubber septum was 
attached to a double manifold and cooled under vacuum. The flask was backfilled with N2, the 
rubber septum was removed, and (DrewPhos)2PdI2 (0.01 equiv) was added. The septum was 
replaced and the flask purged with N2 for 10 minutes. Bu2O, silyl chloride (2 equiv), and 
alkylmagnesium halide (1 equiv) were added sequentially via syringe. The solution was then 
stirred in an oil bath at 50 °C for 24 h. The flask was cooled to rt, a vent needle was added and 
the reaction was quenched with EtOAc (3 mL) then H2O (3 mL) via syringe. The mixture was 
washed 2 times with brine (20 mL) and extracted using EtOAc or Et2O. The combined organic 
layer was dried over MgSO4, filtered, and the solvent removed in vacuo. The crude material was 
purified via silica gel flash chromatography in the indicated solvent. 
 
General Procedure D (Solid Silyl Chlorides): 
 
An oven dried 10 mL Schlenk flask equipped with a magnetic stirbar and rubber septum was 
attached to a double manifold and cooled under vacuum. The flask was backfilled with N2, the 
rubber septum was removed, (DrewPhos)2PdI2 (0.01 equiv) and silyl chloride (2 equiv) were 
added. The septum was replaced and the flask purged with N2 for 10 minutes. Bu2O and 
alkylmagnesium halide (1 equiv) were added sequentially via syringe. The solution was then 
stirred in an oil bath at the indicated temperature for 24 h. The flask was cooled to rt, a vent 
needle was added and the reaction was quenched with EtOAc (3 mL) then H2O (3 mL) via 
syringe. The mixture was washed 2 times with brine (20 mL) and extracted using EtOAc or Et2O. 
The combined organic layer was dried over MgSO4, filtered, and the solvent removed in vacuo. 
The crude material was purified via silica gel flash chromatography in the indicated solvent. 
 
(1) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (1.36 mL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), and [2.29 M] 
isopropylmagnesium bromide S2 (440 µL, 1.0 mmol) were combined under N2 
and stirred at rt for 1 h. After workup, the crude product was purified via silica 
gel flash chromatography (hexanes) to afford 1 as a clear oil (178 mg, 99%): 
1H NMR (600 MHz, CDCl3) δ 7.55 – 7.50 (m, 2H), 7.39 – 7.33 (m, 3H), 1.01 – 
0.94 (m, 7H), 0.26 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 138.8, 134.1, 128.9, 127.8, 17.7, 13.9, -
5.2. 29Si NMR (119 MHz, CDCl3) δ 0.4. Spectra in agreement with previously reported literature.5 
 
(3) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), Et2O (1.32 mL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), 
and [2.1 M] n-butylmagnesium bromide S4 (480 µL, 1.0 mmol) were 




combined under N2 and stirred at rt for 1 h. After workup, the crude product was purified via silica 
gel flash chromatography (hexanes) to afford 3 as a clear oil (192 mg, 99%): 1H NMR (600 MHz, 
CDCl3) δ 7.55 – 7.48 (m, 2H), 7.39 – 7.32 (m, 3H), 1.37 – 1.26 (m, 4H), 0.87 (t, J = 6.9 Hz, 3H), 
0.78 – 0.73 (m, 2H), 0.26 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 139.9, 133.7, 128.9, 127.8, 26.7, 
26.2, 15.6, 13.9, -2.9. 29Si NMR (119 MHz, CDCl3) δ -3.1. Spectra in agreement with previously 
reported literature.5, 8 
 
(4) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
diethyl ether (0.3 mL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), and 
[0.67 M] 3-pentylmagnesium bromide S5 (1.50 mL, 1.0 mmol) were combined 
under N2 and stirred at rt for 24 h. After workup, the crude product was purified 
via silica gel flash chromatography (hexanes) to afford 4 as a clear oil (203 mg, 
99%): 1H NMR (600 MHz, CDCl3) δ 7.55 – 7.50 (m, 2H), 7.38 – 7.34 (m, 3H), 1.54 (dqd, J = 14.7, 
7.5, 5.3 Hz, 2H), 1.38 (dp, J = 14.7, 7.4 Hz, 2H), 0.88 (t, J = 7.4 Hz, 6H), 0.72 (tt, J = 7.5, 5.1 Hz, 
1H), 0.29 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 139.8, 134.0, 128.8, 127.8, 29.04, 21.9, 13.8, -
3.4. 29Si NMR (119 MHz, CDCl3) δ 1.0. Spectra in agreement with previously reported literature.5 
 
(5) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
diethyl ether (1.24 mL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), and 
[1.77 M] cyclopentylmagnesium bromide (0.56 mL, 1.0 mmol) were combined 
under N2 and stirred at rt for 24 h. After workup, crude product was purified via 
silica gel flash chromatography (hexanes) to afford 5 as a clear oil (200 mg, 
99%): 1H NMR (600 MHz, CDCl3) δ 7.56 – 7.52 (m, 2H), 7.40 – 7.32 (m, 3H), 1.83 – 1.72 (m, 2H), 
1.58 – 1.49 (m, 4H), 1.39 – 1.27 (m, 2H), 1.13 (tt, J = 10.8, 8.2 Hz, 1H), 0.26 (s, 6H). 13C NMR 
(151 MHz, CDCl3) δ 139.5, 134.0, 128.8, 127.8, 28.4, 27.2, 25.6, -4.3. 29Si NMR (119 MHz, 
CDCl3) δ -2.0. Spectra in agreement with previously reported literature.5 
 
(6) According to general procedure B, (DrewPhos)2PdI2 
(16 mg, 10 µmol), Et2O (970 µL), dimethylphenylsilyl 
chloride (200 µL, 1.2 mmol), and [1.21 M] (1S,4R)-
bicyclo[2.2.1]heptan-2-ylmagnesium bromide S6 (830 
µL, 1.0 mmol) were combined under N2 and stirred at rt 
for 24 h. After workup, crude product was purified via 
silica gel flash chromatography (hexanes) to afford 6 as an inseparable mixture of exo:endo 
(73:27) diastereomers as a clear oil (150 mg, 65%): Useful diagnostic peaks for each compound 
are listed, mixture matches previously reported spectra.4-5, 9 
6-exo: 1H NMR (600 MHz, CDCl3) δ 2.22 – 2.20 (m, 2H), 1.06 – 1.05 (m, 2H), 0.83 – 0.79 (m, 
1H), 0.24 (s, 3H), 0.22 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 139.5, 134.0, 128.8, 127.8, 38.1, 
37.9, 37.1, 34.5, 32.9, 29.0, 28.7, -3.9, -3.9, 29Si NMR (119 MHz, CDCl3) δ -3.20. 
6-endo: 1H NMR (600 MHz, CDCl3) δ 2.31 (s, 1H), 2.27 (t, J = 4.3 Hz, 1H), 1.77 – 1.70 (m, 1H), 
1.02 (tdd, J = 11.0, 4.9, 2.0 Hz, 1H), 0.31 (s, 3H), 0.28 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 
140.4, 133.9, 128.7, 127.8, 41.9, 39.7, 37.3, 32.0, 30.0, 28.5, 27.6, -2.7, -3.0, 29Si NMR (119 
MHz, CDCl3) δ -2.78. 
 
(7) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
diethyl ether (0.76 mL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), 
and [0.96 M] (trimethylsilyl)methylmagnesium chloride (1.04 mL, 1.0 mmol) 
were combined under N2 and stirred at rt for 24 h. After workup, crude 
product was purified via silica gel flash chromatography (hexanes) to afford 7 as a clear oil (122 
mg, 55%): 1H NMR (600 MHz, CDCl3) δ 7.59 – 7.48 (m, 2H), 7.38 – 7.33 (m, 3H), 0.31 (s, 6H), 
0.02 (s, 2H), -0.01 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 141.5, 133.4, 128.86, 127.8, 3.4, 1.4, 
0.0. 29Si NMR (119 MHz, CDCl3) δ 0.5, -4.2. FTIR (cm-1): 2953, 2897, 1426, 1250, 1113, 1051, 








(8) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (750 µL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), and [0.95 M] 
neopentylmagnesium bromide S7 (1.05 mL, 1.0 mmol) were combined 
under N2 and stirred at rt for 24 h. After workup, crude product was purified 
via silica gel flash chromatography (hexanes) to afford 8 as a clear oil (205 
mg, 99%): 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.52 (m, 2H), 7.42 – 7.29 (m, 3H), 0.95 (s, 11H), 
0.35 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 141.0, 133.6, 128.7, 127.8, 33.2, 33.2, 31.3, -0.4. 29Si 
NMR (119 MHz, CDCl3) δ -5.7. FTIR (cm-1): 2954, 2893, 2869, 1465, 1427, 1363, 1249, 1113, 
832, 707. HRMS (CI) m/z, calcd for C13H22Si+ [M]+: 206.1491; found: 206.1501. 
 
(9) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (50 µL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), and [0.40 M] 
2-methyl-2-phenylpropylmagnesium chloride (2.50 mL, 1.0 mmol) were 
combined under N2 and stirred at rt for 24 h. After workup, crude product 
was purified via silica gel flash chromatography (hexanes) to afford 9 as a 
clear oil (136.2 mg, 51%): 1H NMR (600 MHz, CDCl3) δ 7.42 – 7.37 (m, 2H), 7.33 – 7.32 (m, 2H), 
7.30 – 7.27 (m, 3H), 7.27 – 7.22 (m, 2H), 7.15 – 7.13 (m, 1H), 1.37 (s, 2H), 1.32 (s, 6H), 0.01 (s, 
6H). 13C NMR (151 MHz, CDCl3) δ 151.1, 140.8, 133.6, 128.7, 128.1, 127.8, 125.7, 125.6, 37.5, 
34.2, 32.6, -1.2. 29Si NMR (119 MHz, CDCl3) δ -5.7. FTIR (cm-1): 2959, 2360, 2339, 1652, 1558, 
1456, 1110, 826. 668. HRMS (CI) m/z, calcd for C17H21Si+ [M-CH3]+: 253.1413; found: 253.1417. 
 
(10) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), diethyl ether (1.1 mL), dimethylphenylsilyl chloride (200 µL, 1.2 
mmol), and [1.34 M] (4-phenylbutan-2-yl)magnesium bromide S8 (750 
µL, 1.0 mmol) were combined under N2 and stirred at rt for 24 h. After 
workup, crude product was purified via silica gel flash chromatography 
(hexanes gradient to hexanes:dichloromethane = 95:5) to afford 10 as a clear oil (264 mg, 98%): 
1H NMR (600 MHz, CD2Cl2) δ 7.50 – 7.47 (m, 2H), 7.37 – 7.31 (m, 3H), 7.24 (t, J = 7.5 Hz, 2H), 
7.17 – 7.13 (m, 1H), 7.11 (d, J = 7.5 Hz, 2H), 2.76 (ddd, J = 14.0, 10.4, 4.9 Hz, 1H), 2.46 (ddd, J 
= 13.6, 10.1, 6.7 Hz, 1H), 1.79 (dddd, J = 13.7, 10.3, 6.7, 3.6 Hz, 1H), 1.41 (dtd, J = 13.6, 10.3, 
4.9 Hz, 1H), 1.02 (d, J = 7.2 Hz, 3H), 0.96 – 0.89 (m, 1H), 0.26 (s, 3H), 0.25 (s, 3H), 13C NMR 
(151 MHz, CDCl3) δ 143.0, 138.7, 134.1, 128.9, 128.6, 128.4, 127.8, 125.7, 35.0, 33.9, 19.0, 14.1, 
-4.6, -4.8, 29Si NMR (119 MHz, CDCl3) δ -0.05. Spectra in agreement with previously reported 
literature.5, 10 
 
(11) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), diethyl ether (0.52 mL), dimethylphenylsilyl chloride (200 µL, 
1.2 mmol), and [0.79 M] 4-(4-(chloro)phenyl)butan-2-yl)magnesium 
bromide S9 (1.28 mL, 1.0 mmol) were combined under N2 and 
stirred at rt for 24 h. After workup, crude product was purified via 
silica gel flash chromatography (hexanes) then by reverse phase chromatography on C18 
modified silica (gradient from acetonitrile:water = 50:50 to acetonitrile:water 100:0) to afford 11 as 
a clear oil (272 mg, 89%): 1H NMR (600 MHz, CDCl3) δ 7.52 – 7.43 (m, 2H), 7.40 – 7.32 (m, 3H), 
7.22 (d, J = 8.4 Hz, 2H), 7.03 (d, J = 8.3 Hz, 2H), 2.76 – 2.69 (m, 1H), 2.44 (ddd, J = 13.7, 9.7, 
7.0 Hz, 1H), 1.77 (dddd, J = 13.5, 10.2, 7.0, 3.5 Hz, 1H), 1.40 (dtd, J = 13.9, 10.1, 4.9 Hz, 1H), 
1.02 (d, J = 7.3 Hz, 3H), 0.94 – 0.83 (m, 1H), 0.27 (s, 3H), 0.26 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 141.4, 138.6, 134.1, 131.5, 129.9, 129.0, 128.5, 127.8, 34.3, 33.8, 18.9, 14.1, -4.6, -4.9. 
29Si NMR (119 MHz, CDCl3) δ -0.05. Spectra in agreement with previously reported literature.5 
 
(12) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), diethyl ether (620 µL), dimethylphenylsilyl chloride (200 
µL, 1.2 mmol), and [0.85 M] (4-(4-methoxyphenyl)butan-2-
yl)magnesium bromide S10 (1.18 mL, 1.0 mmol) were combined 
under N2 and stirred at rt for 24 h. After workup, crude product 
was purified via silica gel flash chromatography (hexanes 
gradient to hexanes:dichloromethane = 90:10) to afford 12 as a clear oil (283 mg, 95%): 1H NMR 




(600 MHz, CD2Cl2) δ 7.50 – 7.46 (m, 2H), 7.36 – 7.31 (m, 3H), 7.02 (d, J = 8.6 Hz, 2H), 6.78 (d, J 
= 8.6 Hz, 2H), 3.75 (s, 3H), 2.70 (ddd, J = 14.5, 10.2, 4.9 Hz, 1H), 2.40 (ddd, J = 13.6, 10.0, 6.8 
Hz, 1H), 1.74 (dddd, J = 13.6, 10.2, 6.8, 3.5 Hz, 1H), 1.40 – 1.33 (m, 1H), 1.00 (d, J = 7.3 Hz, 
3H), 0.90 (dqd, J = 11.0, 7.6, 7.2, 3.5 Hz, 1H), 0.25 (s, 3H), 0.24 (s, 3H), 13C NMR (151 MHz, 
CD2Cl2) δ 158.3, 139.2, 135.5, 134.5, 129.8, 129.3, 128.1, 114.1, 55.7, 34.6, 34.4, 19.3, 14.3, -
4.5, -4.7, 29Si NMR (119 MHz, CDCl3) δ -0.17. Spectra in agreement with previously reported 
literature.4-5 
 
(13) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (100 µL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), and [0.55 
M] (1-phenylethyl)magnesium bromide S11 (1.8 mL, 1.0 mmol) were 
combined under N2 and stirred at rt for 24 h. After workup, crude product 
was purified via silica gel flash chromatography (hexanes) then by reverse 
phase chromatography on C18 modifed silica (gradient from 
acetonitrile:water = 50:50 to acetonitrile:water = 75:25) to afford 13 as a clear oil (129 mg, 54%): 
1H NMR (600 MHz, CDCl3) δ 7.40 – 7.30 (m, 5H), 7.19 (t, J = 7.6 Hz, 2H), 7.08 (t, J = 7.3 Hz, 1H), 
6.94 (d, J = 7.2 Hz, 2H), 2.38 (q, J = 7.5 Hz, 1H), 1.33 (d, J = 7.5 Hz, 3H), 0.24 (s, 3H), 0.19 (s, 
3H), 13C NMR (151 MHz, CDCl3) δ 145.2, 137.5, 134.1, 129.0, 127.9, 127.5, 127.3, 124.4, 29.5, 
15.1, -4.4, -5.5, 29Si NMR (119 MHz, CDCl3) δ -1.03. Spectra in agreement with previously 
reported literature.5 
 
(14) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (1.40 mL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), and [2.62 M] 
phenylmagnesium bromide (400 µL, 1.0 mmol) were combined under N2 and 
stirred at rt for 24 h. After workup, crude product was purified via silica gel 
flash chromatography (hexanes) then by reverse phase chromatography on C18 modifed silica 
(gradient from acetonitrile:water = 50:50 to acetonitrile:water = 100:0) to afford 14 as a clear oil 
(215 mg, 97%): 1H NMR (600 MHz, CDCl3) δ 7.61 – 7.50 (m, 4H), 7.40 – 7.35 (m, 6H), 0.59 (s, 
6H). 13C NMR (151 MHz, CDCl3) δ 138.4, 134.4, 129.2, 128.0, -2.2.29Si NMR (119 MHz, CDCl3) δ 
-8.1. Spectra in agreement with previously reported literature.11 
 
(15) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (1.3 mL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), and [2.0 M] 
ortho-tolylmagnesium bromide (0.500 mL, 1.0 mmol) were combined under N2 
and stirred at rt for 24 h. After workup, crude product was purified via silica gel 
flash chromatography (hexanes) to afford 15 as a clear oil (210 mg, 93%): 1H 
NMR (600 MHz, CD2Cl2) δ 7.51 – 7.47 (m, 3H), 7.38 – 7.31 (m, 3H), 7.29 (td, 
J = 7.5, 1.3 Hz, 1H), 7.18 (t, J = 7.4 Hz, 1H), 7.14 (d, J = 7.6 Hz, 1H), 2.25 (s, 3H), 0.58 (s, 6H), 
13C NMR (151 MHz, CD2Cl2) δ 144.7, 139.7, 136.8, 135.9, 134.6, 130.4, 130.1, 129.5, 128.4, 
125.5, 23.5, -1.0, 29Si NMR (119 MHz, CDCl3) δ -8.1, FTIR (cm-1): 3067, 3050, 3003, 2956, 1589, 
1428, 1250, 1130, 1112, 817, 775, 701, 642, 474. HRMS (CI) m/z, calcd for C14H15Si+ [M]+: 
211.0943; found: 211.0952. Spectra in agreement with previously reported literature.12 
 
(16) According to general procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), Et2O (720 µL), dimethylphenylsilyl chloride (200 µL, 1.2 mmol), 
and [0.93 M] 2-mesitylmagnesium bromide (1.08 mL, 1.0 mmol) were 
combined under N2 and stirred at rt for 24 h. After workup, crude product 
was purified via silica gel flash chromatography (hexanes) to afford 16 as 
a clear oil (250 mg, 98%): 1H NMR (400 MHz, CDCl3) δ 7.52 – 7.44 (m, 
2H), 7.35 – 7.29 (m, 3H), 6.84 (s, 2H), 2.30 (s, 6H), 2.29 (s, 3H), 0.63 (s, 
6H). 13C NMR (101 MHz, CDCl3) δ 145.2, 141.7, 139.2, 133.5, 130.8, 129.3, 128.7, 128.0, 25.1, 
21.1, 3.2. 29Si NMR (119 MHz, CDCl3) δ -9.0. FTIR (cm-1): 2954, 1605, 1450, 1427, 1250, 1105, 
816, 701, 667. HRMS (CI) m/z, calcd for C17H22Si+ [M]+: 254.1491; found: 254.1495. 
 
(17) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), Et2O 
(1.04 mL), trimethylsilyl chloride (150 µL, 1.2 mmol), and [1.43 M] (4-




phenylbutan-2-yl)magnesium bromide S8 (700 µL, 1.0 mmol) were combined under N2 and 
stirred at rt for 24 h. After workup, crude product was purified via silica gel flash chromatography 
(hexanes) to afford 17 as a clear oil (154 mg, 75%): 1H NMR (600 MHz, CDCl3) δ 7.29 (t, J = 7.6 
Hz, 2H), 7.21 – 7.16 (m, 3H), 2.81 (ddd, J = 14.8, 10.6, 4.9 Hz, 1H), 2.51 (ddd, J = 13.5, 10.3, 6.6 
Hz, 1H), 1.79 (dddd, J = 13.9, 10.3, 6.5, 3.7 Hz, 1H), 1.49 – 1.33 (m, 1H), 1.01 (d, J = 7.4 Hz, 
3H), 0.65 (dqd, J = 10.9, 7.4, 3.7 Hz, 1H), -0.03 (s, 9H), 13C NMR (151 MHz, CDCl3) δ 143.3, 
128.6, 128.4, 125.7, 35.2, 34.1, 19.6, 14.0, -3.1, 29Si NMR (119 MHz, CDCl3) δ 4.53, FTIR (cm-1): 
3027, 2953, 2865, 1604, 1496, 1454, 1248, 856, 834, 745, 698. HRMS (CI) m/z, calcd for 
[C13H21Si]+: 205.1413; found: 205.1418. 
 
(18) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (950 µL), phenethyldimethylsilyl chloride (240 µL, 1.2 mmol), and 
[1.23 M] (4-phenylbutan-2-yl)magnesium bromide S8 (810 µL, 1.0 
mmol) were combined under N2 and stirred at rt for 24 h. After 
workup, crude product was purified via silica gel flash chromatography 
(hexanes) then by reverse phase chromatography on C18 modifed 
silica (gradient from acetonitrile:water = 75:25 to acetonitrile:water = 95:0) to afford 18 as a clear 
oil (280 mg, 94%): 1H NMR (600 MHz, CD2Cl2) δ 7.29 – 7.23 (m, 4H), 7.22 – 7.12 (m, 6H), 2.82 
(ddd, J = 14.3, 10.5, 4.8 Hz, 1H), 2.59 (dd, J = 11.4, 6.1 Hz, 2H), 2.50 (ddd, J = 13.6, 10.1, 6.7 
Hz, 1H), 1.84 – 1.76 (m, 1H), 1.47 – 1.39 (m, 1H), 1.04 (d, J = 7.4 Hz, 3H), 0.90 – 0.85 (m, 2H), 
0.78 – 0.70 (m, 1H), -0.01 (s, 6H), 13C NMR (151 MHz, CDCl3) δ 145.5, 143.1, 128.6, 128.4, 
127.9, 125.8, 125.7, 35.2, 34.1, 30.2, 18.5, 16.1, 14.0, -4.98, -5.00, 29Si NMR (119 MHz, CDCl3) δ 
5.5. HRMS (CI) m/z, calcd for [C19H25Si]+: 281.1726; found: 281.1716. 
 
(19) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (930 µL), (3,3-dimethylbutyl)dimethylsilyl chloride (250 µL, 
1.2 mmol), and [1.23 M] (4-phenylbutan-2-yl)magnesium bromide 
S8 (810 µL, 1.0 mmol) were combined under N2 and stirred at rt for 
24 h. After workup, crude product was purified via silica gel flash 
chromatography (hexanes) then by reverse phase chromatography 
on C18 modified silica (gradient from acetonitrile:water = 75:25 to 
acetonitrile:water = 100:0) to afford 19 as a clear oil (255 mg, 92%): 1H NMR (600 MHz, CDCl3) δ 
7.28 (t, J = 7.6 Hz, 2H), 7.21 – 7.16 (m, 3H), 2.82 (ddd, J = 14.1, 10.4, 4.8 Hz, 1H), 2.50 (ddd, J = 
13.5, 10.1, 6.7 Hz, 1H), 1.78 (dddd, J = 13.7, 10.3, 6.7, 3.5 Hz, 1H), 1.46 – 1.37 (m, 1H), 1.11 
(ddd, J = 12.7, 5.8, 2.1 Hz, 2H), 1.01 (d, J = 7.4 Hz, 3H), 0.84 (s, 9H), 0.74 – 0.66 (m, 1H), 0.45 – 
0.40 (m, 2H), -0.07 (s, 3H), -0.07 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 143.2, 128.6, 128.4, 
125.7, 38.0, 35.2, 34.1, 31.2, 29.0, 18.4, 14.1, 7.8, -5.1, 29Si NMR (119 MHz, CDCl3) δ 6.14, FTIR 
(cm-1): 3027, 2952, 2913, 2865, 1604, 1466, 1454, 1363, 1248, 1159, 886, 835, 745, 698. HRMS 
(CI) m/z, calcd for [C17H29Si]+: 261.2039; found: 261.2038. 
 
(20) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (1.23 mL), (3,3,3-trifluoropropyl)dimethylsilyl chloride (210 µL, 
1.2 mmol), and [1.78 M] (4-phenylbutan-2-yl)magnesium bromide S8 
(560 µL, 1.0 mmol) were combined under N2 and stirred at rt for 24 h. 
After workup, crude product was purified via silica gel flash 
chromatography (hexanes) to afford 20 as a clear oil (234 mg, 81%): 
1H NMR (600 MHz, CDCl3) δ 7.29 (t, J = 7.6 Hz, 2H), 7.21 – 7.15 (m, 3H), 2.83 (ddd, J = 14.2, 
10.1, 4.8 Hz, 1H), 2.51 (ddd, J = 13.6, 9.8, 6.9 Hz, 1H), 2.03 – 1.89 (m, 2H), 1.77 (dddd, J = 13.6, 
10.2, 6.9, 3.3 Hz, 1H), 1.49 – 1.39 (m, 1H), 1.03 (d, J = 7.4 Hz, 3H), 0.78 – 0.66 (m, 3H), -0.01 (s, 
3H), -0.01 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 142.7, 128.5, 128.5, 127.80 (q, J = 276.7 Hz) 
125.9, 34.9, 33.8, 28.95 (q, J = 29.8 Hz), 18.0, 13.8, 5.5, -5.3, -5.4, 19F NMR (565 MHz, CDCl3) δ 
68.78, 29Si NMR (119 MHz, CDCl3) δ 6.11, FTIR (cm-1): 3028, 2953, 2867, 1604, 1497, 1364, 
1264, 1212, 1125, 1067, 900, 844, 699. HRMS (CI) m/z, calcd for [C15H24F3Si]+: 289.1599; found: 
289.1587. 
  




(21) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), Et2O 
(1.1 mL), chloromethyldimethylsilyl chloride (160 µL, 1.2 mmol), and [1.34 
M] (4-phenylbutan-2-yl)magnesium bromide S8 (750 µL, 1.0 mmol) were 
combined under N2 and stirred at rt for 24 h. After workup, crude product 
was purified via silica gel flash chromatography (hexanes) to afford 21 as 
a clear oil (154 mg, 64%): 1H NMR (600 MHz, CDCl3) δ 7.29 (t, J = 7.7 
Hz, 2H), 7.21 – 7.16 (m, 3H), 2.81 (s, 3H), 2.52 (ddd, J = 13.5, 10.3, 6.5 
Hz, 1H), 1.80 (dddd, J = 13.9, 10.3, 6.5, 3.6 Hz, 1H), 1.51 – 1.42 (m, 1H), 1.05 (d, J = 7.4 Hz, 
3H), 0.90 (dqd, J = 11.1, 7.3, 3.6 Hz, 1H), 0.10 (s, 3H), 0.09 (s, 3H), 13C NMR (151 MHz, CDCl3) 
δ 142.7, 128.5, 128.5, 125.9, 35.0, 33.8, 29.5, 17.6, 13.9, -6.0, -6.1, 29Si NMR (119 MHz, CDCl3) δ 
6.21, FTIR (cm-1): 3027, 2954, 2927, 2865, 1604, 1496, 1454, 1251, 842, 746, 699. HRMS (CI) 
m/z, calcd for [C13H22ClSi]+: 241.1179; found: 241.1182. 
 
(22) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), Et2O (970 µL), 4-chlorobutyldimethylsilyl chloride (220 µL, 
1.2 mmol), and [1.23 M] (4-phenylbutan-2-yl)magnesium bromide 
S8 (810 µL, 1.0 mmol) were combined under N2 and stirred at rt 
for 24 h. After workup, crude product was purified via silica gel 
flash chromatography (hexanes) to afford 22 as a clear oil (247 
mg, 87%): 1H NMR (600 MHz, CDCl3) δ 7.28 (dd, J = 8.3, 6.9 Hz, 2H), 7.21 – 7.14 (m, 3H), 3.53 
(t, J = 6.6 Hz, 2H), 2.81 (ddd, J = 13.6, 10.3, 4.8 Hz, 1H), 2.50 (ddd, J = 13.5, 10.1, 6.7 Hz, 1H), 
1.82 – 1.73 (m, 3H), 1.46 – 1.36 (m, 3H), 1.01 (d, J = 7.4 Hz, 3H), 0.69 (dqd, J = 10.8, 7.3, 3.5 
Hz, 1H), 0.55 – 0.48 (m, 2H), -0.05 (s, 3H), -0.05 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 143.1, 
128.6, 128.4, 125.7, 44.9, 36.4, 35.1, 34.1, 21.4, 18.5, 14.0, 13.1, -4.98, -5.01, 29Si NMR (119 
MHz, CDCl3) δ 5.45, FTIR (cm-1): 3026, 2952, 2931, 2864, 1603, 1496, 1454, 1248, 834, 747, 
699. HRMS (CI) m/z, calcd for [C16H28ClSi]+: 283.1649; found: 283.1658. 
 
(23) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), Et2O (810 µL), 4-bromobutyldimethylsilyl chloride (220 µL, 
1.2 mmol), and [1.34 M] (4-phenylbutan-2-yl)magnesium bromide 
S8 (750 µL, 1.0 mmol) were combined under N2 and stirred at rt 
for 24 h. After workup, crude product was purified via silica gel 
flash chromatography (hexanes) then reverse phase 
chromatography on C18 modified silica (gradient from acetonitle:water = 70:30 to 
acetonitrile:water = 100:0) to afford 23 as a clear oil (302 mg, 92%): 1H NMR (600 MHz, CDCl3) δ 
7.28 (t, J = 7.6 Hz, 2H), 7.18 (d, J = 6.4 Hz, 3H), 3.41 (t, J = 6.8 Hz, 2H), 2.82 (ddd, J = 14.7, 
10.4, 4.8 Hz, 1H), 2.49 (ddd, J = 13.5, 10.1, 6.7 Hz, 1H), 1.85 (p, J = 6.9 Hz, 2H), 1.77 (dddd, J = 
13.7, 10.2, 6.7, 3.4 Hz, 1H), 1.41 (dddd, J = 14.7, 10.3, 6.8, 3.5 Hz, 3H), 1.01 (d, J = 7.3 Hz, 3H), 
0.69 (dqd, J = 10.8, 7.4, 3.4 Hz, 1H), 0.53 – 0.47 (m, 2H), -0.05 (s, 6H), 13C NMR (151 MHz, 
CDCl3) δ 143.1, 128.6, 128.4, 125.7, 36.6, 35.1, 34.1, 33.8, 22.6, 18.4, 14.0, 12.9, -4.98, -5.01, 
29Si NMR (119 MHz, CDCl3) δ 5.42, FTIR (cm-1): 3026, 2951, 2930, 2864, 1603, 1496, 1454, 
1248, 835, 748, 699. HRMS (CI) m/z, calcd for [C15H24BrSi]+: 311.0831; found: 311.0842. 
 
(24) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), Et2O (950 µL), 5-hexenyldimethylsilyl chloride (240 µL, 
1.2 mmol), and [1.23 M] (4-phenylbutan-2-yl)magnesium 
bromide S8 (810 µL, 1.0 mmol) were combined under N2 and 
stirred at rt for 24 h. After workup, crude product was purified 
via silica gel flash chromatography (hexanes) then reverse 
phase chromatography on C18 modified silica (gradient from acetonitle:water = 70:30 to 
acetonitrile:water = 100:0) to afford 24 as a clear oil (251 mg, 91%): 1H NMR (600 MHz, CDCl3) δ 
7.31 – 7.26 (m, 2H), 7.20 – 7.15 (m, 3H), 5.80 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 4.99 (dq, J = 17.1, 
1.5 Hz, 1H), 4.95 – 4.91 (m, 1H), 2.84 – 2.77 (m, 1H), 2.49 (ddd, J = 13.5, 10.2, 6.6 Hz, 1H), 2.04 
(q, J = 7.0 Hz, 2H), 1.77 (dddd, J = 13.7, 10.2, 6.6, 3.5 Hz, 1H), 1.45 – 1.35 (m, 3H), 1.31 – 1.24 
(m, 2H), 1.00 (d, J = 7.4 Hz, 3H), 0.68 (dqd, J = 10.8, 7.4, 3.5 Hz, 1H), 0.53 – 0.47 (m, 2H), -0.07 
(s, 3H), -0.07 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 143.2, 139.3, 128.6, 128.4, 125.7, 114.3, 




35.2, 34.1, 33.6, 33.1, 23.6, 18.6, 14.1, 13.7, -4.9, 29Si NMR (119 MHz, CDCl3) δ 5.31. FTIR (cm-
1): 3063, 3027, 2923, 2854, 1641, 1604, 1496, 1454, 1248, 909, 834, 746, 698. HRMS (CI) m/z, 
calcd for [C17H27Si]+: 259.1882; found: 259.1882. 
 
(25) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), Et2O 
(1.0 mL), pentafluorophenyldimethylsilyl chloride (230 µL, 1.2 mmol), and 
[1.34 M] (4-phenylbutan-2-yl)magnesium bromide S8 (750 µL, 1.0 mmol) 
were combined under N2 and stirred at rt for 24 h. After workup, crude 
product was purified via silica gel flash chromatography (hexanes) to 
afford 25 as a clear oil (227 mg, 63%): 1H NMR (600 MHz, CD2Cl2) δ 7.25 
(t, J = 7.6 Hz, 2H), 7.15 (t, J = 7.4 Hz, 1H), 7.12 (d, J = 7.2 Hz, 2H), 2.80 
(ddd, J = 14.6, 10.3, 4.9 Hz, 1H), 2.49 (ddd, J = 13.5, 10.0, 6.7 Hz, 1H), 
1.76 (dddd, J = 13.7, 10.2, 6.7, 3.4 Hz, 1H), 1.45 (dddd, J = 16.9, 12.2, 
8.5, 3.5 Hz, 1H), 1.09 (dp, J = 12.3, 4.7, 4.1 Hz, 1H), 1.04 (d, J = 6.9 Hz, 
3H), 0.39 (s, 3H), 0.38 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 149.2 (dddt, J = 241.4, 17.4, 8.7, 4.0 
Hz), 142.5, 142.0 (dtt, J = 254.3, 12.9, 5.7 Hz), 138.3 – 136.2 (m), 128.5, 125.9, 110.0 – 109.3 
(m), 34.9, 33.6, 19.0, 13.8, -3.34 (dt, J = 14.4, 3.7 Hz), 19F NMR (565 MHz, CD2Cl2) δ -126.48 – -
126.61 (m), -152.97 (t, J = 19.8 Hz), -162.37 (td, J = 22.6, 8.6 Hz), 29Si NMR (119 MHz, CDCl3) δ 
4.07, FTIR (cm-1): 3028, 2955, 2868, 1642, 1517, 1457, 1374, 1283, 1256, 1086, 969, 841, 802, 
747, 699. HRMS (CI) m/z, calcd for [C17H16F5Si]+: 343.0941; found: 343.0945. 
 
(26) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 
µmol), Et2O (1.3 mL), 4-biphenyldimethylsilyl chloride (300 mg, 
1.2 mmol), and [1.43 M] (4-phenylbutan-2-yl)magnesium bromide 
S8 (700 µL, 1.0 mmol) were combined under N2 and stirred at rt 
for 24 h. After workup, crude product was purified via silica gel 
flash chromatography (hexanes) then reverse phase 
chromatography on C18 modified silica (gradient from 
acetonitle:water = 80:20 to acetonitrile:water = 90:10) to afford 26 as a clear oil (287 mg, 83%): 
1H NMR (600 MHz, CD2Cl2) δ 7.64 – 7.61 (m, 2H), 7.61 – 7.55 (m, 4H), 7.45 (t, J = 7.6 Hz, 2H), 
7.36 (t, J = 7.3 Hz, 1H), 7.25 (t, J = 7.5 Hz, 2H), 7.14 (t, J = 6.3 Hz, 3H), 2.84 – 2.76 (m, 1H), 2.53 
– 2.44 (m, 1H), 1.87 – 1.78 (m, 1H), 1.48 – 1.39 (m, 1H), 1.06 (t, J = 5.9 Hz, 3H), 1.00 – 0.92 (m, 
1H), 0.31 – 0.27 (m, 6H), 13C NMR (151 MHz, CDCl3) δ 143.0, 141.7, 141.3, 137.4, 134.6, 128.9, 
128.6, 128.4, 127.5, 127.3, 126.5, 125.7, 35.0, 33.9, 19.0, 14.2, -4.5, -4.7, 29Si NMR (119 MHz, 
CDCl3) δ -0.04, FTIR (cm-1): 3062, 3025, 2952, 2863, 1597, 1496, 1485, 1454, 1384, 1250, 1115, 
1007, 826, 811, 756, 697. HRMS (CI) m/z, calcd for [C23H25Si]+: 329.1726; found: 329.1731. 
 
(27) According to procedure B, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Et2O (1.0 mL), 3-phenoxydimethylsilyl chloride (285 µL, 1.2 mmol), 
and [1.43 M] (4-phenylbutan-2-yl)magnesium bromide S8 (700 µL, 
1.0 mmol) were combined under N2 and stirred at rt for 24 h. After 
workup, crude product was purified via silica gel flash 
chromatography (hexanes) then reverse phase chromatography on 
C18 modified silica (gradient from acetonitle:water = 80:20 to 
acetonitrile:water = 90:10) to afford 27 as a clear oil (314 mg, 87%): 1H NMR (600 MHz, CD2Cl2) 
δ 7.32 (q, J = 7.5 Hz, 3H), 7.26 – 7.22 (m, 3H), 7.18 – 7.13 (m, 2H), 7.11 (d, J = 7.1 Hz, 2H), 7.09 
(t, J = 7.4 Hz, 1H), 7.00 – 6.95 (m, 3H), 2.76 (ddd, J = 14.9, 10.4, 4.9 Hz, 1H), 2.46 (ddd, J = 
13.5, 10.2, 6.6 Hz, 1H), 1.78 (dddd, J = 13.8, 10.3, 6.6, 3.6 Hz, 1H), 1.40 (dtd, J = 13.6, 10.2, 4.9 
Hz, 1H), 1.02 (d, J = 7.3 Hz, 3H), 0.96 – 0.87 (m, 1H), 0.25 (s, 3H), 0.24 (s, 3H), 13C NMR (151 
MHz, CD2Cl2) δ 158.2, 157.0, 143.5, 141.7, 130.3, 129.7, 129.6, 128.9, 128.8, 126.1, 125.1, 
123.5, 120.0, 118.9, 35.4, 34.4, 19.4, 14.3, -4.5, -4.8, 29Si NMR (119 MHz, CDCl3) δ 0.34, FTIR 
(cm-1): 3061, 3026, 2952, 2864, 1566, 1489, 1476, 1401, 1226, 1110, 812, 771, 697. HRMS (CI) 
m/z, calcd for [C23H25SiO]+: 345.1675; found: 345.1685. 
  




(28) According to procedure C, (DrewPhos)2PdI2 (16 mg, 10 µmol), Bu2O 
(910 µL), triethylsilyl chloride (340 µL, 2 mmol), and [1.34 M] (4-
phenylbutan-2-yl)magnesium bromide S8 (750 µL, 1.0 mmol) were 
combined under N2 and stirred at rt for 24 h. After workup, crude product 
was purified via silica gel flash chromatography (hexanes) to afford 28 as a 
clear oil (249 mg, 99%): 1H NMR (600 MHz, CDCl3) δ 7.28 (t, J = 7.6 Hz, 2H), 7.20 – 7.15 (m, 
3H), 2.84 (ddd, J = 14.1, 10.5, 4.8 Hz, 1H), 2.48 (ddd, J = 13.5, 10.2, 6.7 Hz, 1H), 1.80 (dddd, J = 
13.6, 10.0, 6.6, 3.1 Hz, 1H), 1.50 – 1.41 (m, 1H), 1.04 (d, J = 7.4 Hz, 3H), 0.93 (t, J = 8.0 Hz, 9H), 
0.81 (dqd, J = 10.6, 7.4, 3.3 Hz, 1H), 0.54 (q, J = 8.0 Hz, 6H), 13C NMR (151 MHz, CDCl3) δ 
143.2, 128.6, 128.4, 125.7, 35.3, 34.3, 16.7, 14.3, 7.8, 2.3, 29Si NMR (119 MHz, CDCl3) δ 8.21, 
FTIR (cm-1): 3027, 2952, 2909, 2874, 1604, 1496, 1454, 1416, 1238, 1016, 730, 698. HRMS (CI) 
m/z, calcd for [C16H27Si]+: 247.1882; found: 247.1884. 
 
(29) According to procedure C, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Bu2O (880 µL), cyclohexyldimethylsilyl chloride (370 µL, 2 mmol), and 
[1.34 M] (4-phenylbutan-2-yl)magnesium bromide S8 (750 µL, 1.0 
mmol) were combined under N2 and stirred at rt for 24 h. After workup, 
crude product was purified via silica gel flash chromatography 
(hexanes) to afford 29 as a clear oil (210 mg, 90%): 1H NMR (600 
MHz, CDCl3) δ 7.28 (t, J = 7.6 Hz, 2H), 7.20 – 7.15 (m, 3H), 2.82 (ddd, J = 14.3, 10.5, 4.8 Hz, 
1H), 2.48 (ddd, J = 13.5, 10.2, 6.7 Hz, 1H), 1.78 (dddd, J = 13.6, 10.1, 6.6, 3.2 Hz, 1H), 1.74 – 
1.67 (m, 3H), 1.61 (dd, J = 26.0, 13.0 Hz, 2H), 1.46 – 1.36 (m, 1H), 1.24 – 1.15 (m, 3H), 1.13 – 
1.03 (m, 2H), 1.01 (d, J = 7.4 Hz, 3H), 0.74 (dqd, J = 10.7, 7.4, 3.3 Hz, 1H), 0.68 (tt, J = 12.7, 3.0 
Hz, 1H), -0.11 (s, 3H), -0.12 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 143.3, 128.6, 128.4, 125.7, 
35.2, 34.2, 28.37, 28.36, 27.9, 27.8, 27.2, 24.3, 17.2, 14.2, -6.9, 29Si NMR (119 MHz, CDCl3) δ 
5.66, FTIR (cm-1): 3026, 2919, 2847, 1604, 1496, 1446, 1246, 1099, 996, 888, 833, 799, 767, 
698. HRMS (CI) m/z, calcd for [C18H29Si]+: 273.2039; found: 273.2031. 
 
(30) According to procedure C, (DrewPhos)2PdI2 (16 mg, 10 µmol), Bu2O 
(950 µL), isopropyldimethylsilyl chloride (310 µL, 2 mmol), and [1.34 M] 
(4-phenylbutan-2-yl)magnesium bromide S8 (750 µL, 1.0 mmol) were 
combined under N2 and stirred at rt for 24 h. After workup, crude product 
was purified via silica gel flash chromatography (hexanes) to afford 30 as 
a clear oil (210 mg, 90%): 1H NMR (600 MHz, CDCl3) δ 7.28 (t, J = 7.6 
Hz, 2H), 7.20 – 7.15 (m, 3H), 2.83 (ddd, J = 14.8, 10.6, 4.8 Hz, 1H), 2.49 (ddd, J = 13.5, 10.3, 6.6 
Hz, 1H), 1.78 (dddd, J = 13.7, 10.1, 6.6, 3.2 Hz, 1H), 1.41 (ddt, J = 14.0, 10.5, 5.3 Hz, 1H), 1.02 
(d, J = 7.4 Hz, 3H), 0.95 – 0.90 (m, 6H), 0.88 – 0.81 (m, 1H), 0.76 (dqd, J = 10.7, 7.4, 3.3 Hz, 
1H), -0.10 (s, 3H), -0.11 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 143.2, 128.6, 128.4, 125.7, 35.2, 
34.3, 18.0, 17.9, 17.5, 14.2, 12.1, -7.20, -7.23, FTIR (cm-1): 3027, 2953, 2864, 1604, 1496, 1454, 
1249, 997, 883, 832, 808, 765, 697. HRMS (CI) m/z, calcd for [C14H23Si]+: 219.1569; found: 
219.1559. 
 
(31) According to procedure C, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Bu2O (850 µL), diphenylmethylsilyl chloride (410 µL, 2 mmol), and [1.34 
M] (4-phenylbutan-2-yl)magnesium bromide S8 (750 µL, 1.0 mmol) were 
combined under N2 and stirred at rt for 24 h. After workup, crude product 
was purified via silica gel flash chromatography (hexanes) to afford 31 
as a clear oil (315 mg, 95%): 1H NMR (600 MHz, CD2Cl2) δ 7.50 – 7.47 (m, 4H), 7.39 – 7.31 (m, 
6H), 7.24 (t, J = 7.5 Hz, 2H), 7.16 (t, J = 7.4 Hz, 1H), 7.10 (d, J = 7.1 Hz, 2H), 2.80 (ddd, J = 14.1, 
9.9, 4.8 Hz, 1H), 2.50 (ddd, J = 13.5, 9.5, 7.2 Hz, 1H), 1.91 – 1.82 (m, 1H), 1.51 – 1.43 (m, 1H), 
1.41 – 1.33 (m, 1H), 1.09 (d, J = 7.3 Hz, 3H), 0.53 (s, 3H), 13C NMR (151 MHz, CD2Cl2) δ 143.4, 
137.4, 137.2, 135.40, 135.37, 129.7, 129.6, 129.1, 128.8, 128.37, 128.35, 126.2, 35.4, 34.5, 17.8, 
14.5, -6.2, 29Si NMR (119 MHz, CDCl3) δ -4.7, FTIR (cm-1): 3068, 2953, 2856, 1603, 1495, 1427, 
1251, 1110, 788, 737, 698, 476. HRMS (CI) m/z, calcd for [C22H23Si]+: 315.1569; found: 
315.1579. 
 




(32) According to procedure D, (DrewPhos)2PdI2 (16 mg, 10 µmol), Bu2O 
(1.25 mL), triphenylsilyl chloride (590 mg, 2 mmol), and [1.34 M] (4-
phenylbutan-2-yl)magnesium bromide S8 (750 µL, 1.0 mmol) were 
combined under N2 and stirred at 50 °C for 24 h. After workup, crude 
product was purified via silica gel flash chromatography (hexanes:DCM 
100:0 to hexanes:DCM 90:10) to afford 32 as a viscous clear oil (267 mg, 68%): 1H NMR (600 
MHz, CD2Cl2) δ 7.50 (dd, J = 8.0, 1.4 Hz, 6H), 7.42 – 7.37 (m, 3H), 7.37 – 7.31 (m, 6H), 7.26 (t, J 
= 7.5 Hz, 2H), 7.17 (t, J = 7.4 Hz, 1H), 7.12 (d, J = 7.0 Hz, 2H), 2.86 (ddd, J = 13.8, 9.3, 4.7 Hz, 
1H), 2.57 (dt, J = 13.5, 8.3 Hz, 1H), 2.09 – 2.02 (m, 1H), 1.75 – 1.68 (m, 1H), 1.52 – 1.44 (m, 1H), 
1.21 (d, J = 7.3 Hz, 3H), 13C NMR (151 MHz, CDCl3) δ 143.2, 136.5, 135.2, 129.9, 129.2, 128.8, 
128.4, 126.3, 35.3, 34.7, 16.7, 14.8, 29Si NMR (119 MHz, CD2Cl2) δ -8.7, FTIR (cm-1): 3067, 
3024, 2935, 2856, 1602, 1495, 1428, 1189, 1108, 998, 741, 698, 575, 510. HRMS (CI) m/z, calcd 
for [C22H23Si]+: 315.1569; found: 315.1578. 
 
(33) According to procedure D, (DrewPhos)2PdI2 (16 mg, 10 µmol), 
Bu2O (1.25 mL), tert-butyldimethylsilyl chloride (300 mg, 2 mmol), and 
[1.34 M] (4-phenylbutan-2-yl)magnesium bromide S8 (750 µL, 1.0 
mmol) were combined under N2 and stirred at 100 °C for 24 h. After 
workup, crude product was purified via silica gel flash chromatography 
(hexanes) to afford 33 as a clear oil (74 mg, 30%): 1H NMR (600 MHz, 
CD2Cl2) δ 7.26 (t, J = 7.6 Hz, 2H), 7.20 – 7.14 (m, 3H), 2.83 (ddd, J = 13.7, 10.5, 4.8 Hz, 1H), 
2.48 (ddd, J = 13.4, 10.2, 6.6 Hz, 1H), 1.85 (dddd, J = 13.5, 10.2, 6.6, 2.9 Hz, 1H), 1.48 – 1.39 
(m, 1H), 1.07 (d, J = 7.4 Hz, 3H), 0.89 (s, 9H), 0.85 (ddq, J = 15.0, 7.5, 4.5, 3.6 Hz, 1H), -0.070 
(s, 3H), -0.075 (s, 3H), 13C NMR (151 MHz, CDCl3) δ 143.2, 128.6, 128.4, 125.7, 35.2, 35.0, 27.6, 
17.6, 17.4, 15.2, -7.0, 29Si NMR (119 MHz, CDCl3) δ 9.7, FTIR (cm-1): 3027, 2928, 2856, 1604, 



















An oven dried 200 mL round bottom flask equipped with a magnetic stirbar and rubber septum 
was attached to a double manifold and cooled under vacuum. The flask was backfilled with N2, 
the septum removed, magnesium turnings (5.8 g, 240 mmol, 1.2 equiv) and two chips of I2 (~50–
70 mg) were added. The septum was replaced; the flask was attached to a double manifold and 
purged with N2 for 10 min. The flask was held under positive N2 then Et2O (67 mL, [3 M]) was 
added. The solution was stirred until clarity was reached (disappearance of brown I2 color). An 
initial amount of isopropyl bromide (1.5 mL) was added to start the reaction as evidenced by a 
minor exotherm. If reaction does not initiate, gentle warming (for example with a heating mantle) 
may be necessary. Once initiated, the flask was cooled to 0 °C in an ice/water bath and the 
remaining isopropyl bromide was added dropwise over 30 minutes for a total addition of 18.8 mL 
(24.6 g, 200 mmol, 1 equiv). After full addition of isopropyl bromide, the flask was allowed to stir 
at rt for an additional 2 h. The excess magnesium was allowed to settle and the mixture was 
filtered via cannula to a Schlenk tube. If insoluble particles persist, filtration through a 0.2 µm 
PTFE syringe filter may be employed. Titrated according to the literature procedure by Knochel6 






An oven dried 500 mL Schlenk flask equipped with a magnetic stirbar and rubber septum was 
attached to a double manifold and cooled under vacuum. The flask was backfilled with N2, the 
rubber septum was removed, and (DrewPhos)2PdI2 (1.558 g, 1 mmol, 0.01 equiv) was added. 
The septum was replaced and the flask purged with N2 for 15 minutes. Et2O (136 mL), silyl 
chloride (17.9 g, 17.6 mL, 105 mmol, 1 equiv), and [2.12 M] isopropylmagnesium bromide (47.2 
mL, 100 mmol, 1 equiv) were added sequentially via syringe. The solution was then stirred at rt 
for 24 h. The flask was then placed in a room temperature water bath. The septum was removed 
and EtOAc (20 mL) was added followed by a slow addition of water. (Note: Water quenching 
results in an exotherm.) Water was added until the salts formed were completely solubilized. The 
mixture was then poured into a separatory funnel and washed with 100 mL brine. The aqueous 
layer was back extracted with 75 mL EtOAc. The combined organic layer was dried over MgSO4, 
filtered, and the solvent removed in vacuo. EtOH (50 mL) was then added and thoroughly swirled 
to ensure even mixing. This flask was then placed in a –20 °C freezer for 24 h. Red solid 
precipitated from the solution and was then collected via suction filtration, rinsing with EtOH as 
necessary. This yielded 1.12 g of (DrewPhos)2PdX2 (X = I:Br:Cl 88:11:1) as determined by 31P 
NMR. The filtrate was then concentrated in vacuo then distilled at 10 mm Hg / 79 °C to afford 1 
as a clear oil (17.2 g, 96%): 1H NMR (600 MHz, CDCl3) δ 7.53 – 7.49 (m, 2H), 7.38 – 7.33 (m, 
3H), 0.98 – 0.95 (m, 7H), 0.25 (s, 6H). 
 
 




Activity of Recovered Catalyst Mixture: 
 
Note: The recovered catalyst from the scale up reaction was obtained as a mixture of palladium 
halide salts (as determined by 31P NMR), with the iodo-complex being the predominant 
constituent. The fact that this mixed halide catalyst has similar reactivity to the pure iodo-complex 
was established using the following study: 
 
In a nitrogen filled glovebox, a 1-dram vial equipped with a magnetic stirbar was charged with 
(DrewPhos)2PdX2 (88:11:1, I:Br:Cl) (4 mg, 2.5 µmol, 0.01 equiv), Et2O (340 µL), and 
dimethylphenylsilyl chloride (50 µL, 51 mg, 300 µmol, 1.2 equiv). Vial was then sealed with a 
septum cap and removed from GB. Isopropylmagnesium bromide [2.29 M] (109 µL, 250 µmol, 1 
equiv) was then added via syringe and the vial was then stirred at rt for 24 h. The reaction was 
quenched with Et2O (1 mL) then H2O (0.5 mL) via syringe. n-Nonane (32 mg, 45 µL, 0.25 mmol, 1 
equiv) and 1,3,5-trimethoxybenzene (TMB) (14 mg, 0.25 mmol, 0.33 equiv) were added as GC 
internal standards. Brine (1 mL) and Et2O (1 mL) were then added and the vials shaken. An 
aliquot was then filtered through a MgSO4 and silica plug. The solution was directly analyzed by 









7. All Chloride Experiments: 
 
Synthesis of Chloride Reagents: 
 
 
(DrewPhos)2PdCl2: A 100 mL round bottom flask 
equipped with a magnetic stirbar was charged with 
bis(acetonitrile)dichloropalladium(II) (259 mg, 1 
mmol, 1.0 equiv) and DrewPhos (1.2 g, 2 mmol, 2.0 
equiv). The flask was sealed with a rubber septum 
and purged 10 min with N2. CH2Cl2 (20 mL) was 
added via syringe and the solution was stirred for 6 
hours at rt. The solvent was then removed in vacuo. 
EtOAc (15 mL) was added and the flask sat 
overnight at rt. The solid was collected via vacuum 
filtration and rinsing with EtOH resulted in a stable, 
yellow solid (905 mg, 66% yield): 1H NMR (600 MHz, CDCl3) δ 7.52 – 7.48 (m, 12H), 7.38 (s, 6H), 
1.19 (s, 108H); 13C NMR (151 MHz, CDCl3) δ 149.69 (t, J = 5.0 Hz), 130.41 (t, J = 23.9 Hz), 
129.87 (t, J = 6.4 Hz), 123.83 , 35.01 , 31.54,31P NMR (243 MHz, CDCl3) δ 26.82; FTIR (cm-1): 
2963, 2903, 2868, 1590, 1477, 1421, 1363, 1266, 1249, 1138, 731, 705, 586; mp =  >250 °C. 
HRMS (LIFDI) m/z, calcd for [C84H126P2PdCl2]+:1372.7747; found: 1372.7599. 
 
 
An oven-dried 25 mL round-bottom flask equipped with a magnetic stirbar and 
rubber septum was attached to a double manifold and cooled under vacuum. The 
flask was backfilled with N2, the septum removed, magnesium turnings (1.1 g, 45 
mmol, 1.5 equiv) were added. The septum was replaced; the flask was attached 
to a double manifold and purged with N2 for 10 min. The flask was held under 
positive N2 then Et2O (10 mL, [3 M]) was added. An initial amount of alkyl halide (~200–400 µL) 
was added and the reaction to start the reaction as evidenced by a minor exotherm. If reaction 
does not initiate, gentle warming (for example with a heating mantle) may be necessary. Once 
initiated, the flask was placed in a rt water bath and the remaining alkyl halide (2.74 mL, 2.36 g, 
30 mmol, 1 equiv, total addition amount) was added dropwise over ~30 min. After full addition of 
the alkyl halide, the mixture was allowed to stir at rt for an additional 4 h. The excess magnesium 
was allowed to settle and the mixture was filtered via cannula to a Schlenk tube. Titration resulted 
in a [2.65 M] solution of isopropylmagnesium chloride. Note: In this preparation, I2 was not used 
to activate the magnesium turnings. 
 
 
All Chloride Reactions: 
 
 
In a nitrogen filled glovebox, a 1-dram vial equipped with a magnetic stirbar was charged with 
(DrewPhos)2PdCl2 (3.4 mg, 2.5 µmol, 0.01 equiv), Et2O (350 µL) or Bu2O (350 µL), and 
dimethylphenylsilyl chloride (50 µL, 51 mg, 300 µmol, 1.2 equiv). Vial was then sealed with a 
septum cap and removed from the glovebox. Isopropylmagnesium chloride [2.65 M] (94 µL, 250 
µmol, 1 equiv) was then added via syringe and the vial was then stirred at the indicated 
temperature for 24 h. The reaction was quenched with Et2O (1 mL) then H2O (0.5 mL) via syringe. 
n-Nonane (32 mg, 45 µL, 0.25 mmol, 1 equiv) and 1,3,5-trimethoxybenzene (TMB) (14 mg, 0.25 
mmol, 0.33 equiv) were added as GC internal standards. Brine (1 mL) and Et2O (1 mL) were then 
added and the vials shaken. An aliquot was then filtered through a MgSO4 and silica plug. The 





















Table S1. All Chloride Conditions 
 
 
Entry Solvent Temp Additive Yield (%)a 
1 Et2O rt --- 6 
2 Bu2O 50 °C --- 70 
3 Et2O rt 0.25 equiv TMEDA 52 








8. Additional Optimization Data: 
 
Note: All reactions in this section were performed on 0.25 mmol in a nitrogen-filled glovebox with 
a [0.5 M] overall concentration based on the sum of all liquid reagents. 
 
Examination of Stoichiometry: 
 
 
In a nitrogen filled glovebox, a 1-dram vial equipped with a magnetic stirbar was charged with 
(DrewPhos)2PdI2 (4 mg, 2.5 µmol, 0.01 equiv), Et2O (330 µL), and dimethylphenylsilyl chloride 
(52 µL, 53 mg, 313 µmol, 1.25 equiv, or 46 µL, 47 mg, 275 µmol, 1.1 equiv, or 42 µL, 43 mg, 250 
µmol, 1 equiv). Vial was then sealed with a septum cap and removed from the glovebox. 
Isopropylmagnesium bromide [2.13 M] (117 µL, 250 µmol, 1 equiv, or 129 µL, 275 µL, 1.1 equiv, 
or 147 µL, 313 µmol, 1.25 equiv) was then added via syringe and the vial was then stirred at rt for 
the indicated time. The reaction was quenched with Et2O (1 mL) then H2O (0.5 mL) via syringe. n-
Nonane (32 mg, 45 µL, 0.25 mmol, 1 equiv) and 1,3,5-trimethoxybenzene (TMB) (14 mg, 0.25 
mmol, 0.33 equiv) were added as GC internal standards. Brine (1 mL) and Et2O (1 mL) were then 
added and the vials shaken. An aliquot was then filtered through a MgSO4 and Silica plug. The 
solution was directly analyzed by GC. 
 
 
Table S2. Effect of Stoichiometry 
 
 
Entry Mg:Si 4 h (%)a 8 h (%)a 24 h (%)a 
1 1:1.25 99 99 99 
2 1:1.1 78 96 99 
3 1:1 73 90 97 
4 1.1:1 74 88 93 
5 1.25:1 71 86 93 




Examination of Ethereal Solvents: 
 
 
In a nitrogen filled glovebox, a 1-dram vial equipped with a magnetic stirbar was charged with 
(DrewPhos)2PdI2 (4 mg, 2.5 µmol, 0.01 equiv), MTBE or CPME (280 µL), and triethylsilyl chloride 
(84 µL, 75 mg, 500 µmol, 2 equiv) or iso-propyldimethylsilyl chloride (78 µL, 68 mg, 500 µmol, 2 
equiv). Vial was then sealed with a septum cap and removed from the glovebox. (4-phenylbutan-
2-yl)magnesium bromide [1.78 M] (140 µL, 250 µmol, 1 equiv) was then added via syringe and 
the vial was then stirred at 50 °C for the indicated time. The reaction was quenched with Et2O (1 
mL) then H2O (0.5 mL) via syringe. n-Nonane (32 mg, 45 µL, 0.25 mmol, 1 equiv) and 1,3,5-
trimethoxybenzene (TMB) (14 mg, 0.25 mmol, 0.33 equiv) were added as GC and NMR internal 
standards. Brine (1 mL) and Et2O (1 mL) were then added and the vials shaken. An aliquot was 
then filtered through a MgSO4 and Silica plug. The solution was directly analyzed by GC then 











Table S3. Examination of Ethereal Solvents 
 
 
Entry [Si] MTBEa CPMEa 
1 Et3Si 99 99 
2 iPrMe2Si 97 90 
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